Group L. P. Column serves as Executive at NGM BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Group L. P. Column has executed 63 insider transactions totaling $28.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 31, 2020 involved purchasing 118,067 shares valued at $1.5M.
Group L. P. Column currently holds 949,862 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Group L. P. Column has been a net buyer of NGM stock. They have purchased $28.5M and sold $0 worth of shares.
Group L. P. Column's most recent insider trade was on Mar 31, 2020, when they purchased 118,067 shares at $12.53 per share.
Get notified when new Form 4 filings are submitted
| $12.49 |
| Discretionary |
| Mar 24, 2020 | NGM | $1.6M | Purchase | 128,377 | $12.22 | Discretionary |
| Mar 23, 2020 | NGM | $2.0M | Purchase | 170,387 | $11.63 | Discretionary |
| Mar 20, 2020 | NGM | $1.7M | Purchase | 143,082 | $11.77 | Discretionary |
| Mar 19, 2020 | NGM | $1.7M | Purchase | 148,464 | $11.59 | Discretionary |
| Mar 5, 2020 | NGM | $149.5K | Purchase | 8,307 | $18.00 | Discretionary |
| Oct 21, 2019 | NGM | $518.2K | Purchase | 43,400 | $11.94 | Discretionary |
| Oct 18, 2019 | NGM | $392.0K | Purchase | 34,721 | $11.29 | Discretionary |
| Oct 17, 2019 | NGM | $72.4K | Purchase | 6,818 | $10.62 | Discretionary |
| Oct 16, 2019 | NGM | $358.1K | Purchase | 34,900 | $10.26 | Discretionary |
| Oct 15, 2019 | NGM | $342.3K | Purchase | 33,200 | $10.31 | Discretionary |
| Oct 14, 2019 | NGM | $361.6K | Purchase | 34,900 | $10.36 | Discretionary |